Gam Holding Ag Global Blood Therapeutics, Inc. Transaction History

Gam Holding Ag

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 09, 2021	SELL	$32.46 - $43.42 $830,976 - $1.11 Million	-25,600 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$38.94 - $50.85 $996,864 - $1.3 Million	25,600 New	25,600 $1.04 Million
Q4 2020 Feb 10, 2021	SELL	$37.65 - $63.77 $2.07 Million - $3.5 Million	-54,900 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$52.76 - $74.49 $1.76 Million - $2.48 Million	33,300 Added 154.17%	54,900 $3.03 Million
Q2 2020 Aug 10, 2020	BUY	$48.73 - $81.82 $1.05 Million - $1.77 Million	21,600 New	21,600 $1.36 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Gam Holding Ag, based on Form 13F filings with the SEC.

Stay updated on Gam Holding Ag with notifications on news.